Interactions of uPAR: Impact on receptor regulation and signal transduction

Fibrinolysis and Proteolysis

Volumn 12, Issue 4, 1998, Pages 211-217

  Ehart, M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE RECEPTOR;

CELL SURFACE; DRUG RECEPTOR BINDING; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENETIC REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031767903     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(98)80015-5     Document Type: Review

References (74)

1. Ploug M, Ronne E, Behrendt N, Jensen A L, Blasi F, Danø K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 1991; 266: 1926-1933.
2. Nielsen L S, Kellerman G M, Behrendt N, Picone R, Danø K, Blasi F. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. J Biol Chem 1988; 263: 2358-2363.
3. Behrendt N, Ronne E, Ploug M, et al. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem 1990; 265: 6453-6460.
4. Danø K, Behrendt N, Brunner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8 suppl 1: 189-203.
5. Wei Y, Lukashev M, Simon D I, et al. Regulation of integrin function by the urokinase receptor. Science 1996; 273: 1551-1555.
6. Simon D I, Rao N K, Xu H, et al. Mac-1 (GD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 1996; 88: 3185-3194.
7. Kirchheimer J C, Christ G, Binder B R. Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzyme. Eur J Biochem 1989; 181: 103-107
8. Kirchheimer J C, Wojta J, Christ G, Binder B R. Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J 1987; 1: 125-128.
9. Stahl A, Mueller B M. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 1994; 54: 3066-3071.
10. Howell A L, Hunt J A, James T W, Mazar A, Henkin J, Zacharski L R. Urokinase inhibits HL-60 cell proliferation in vitro. Blood Coagul Fibrinolysis 1994; 5: 445-453.
11. Kirchheimer J C, Wojta J, Christ G, Binder B R. Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line. Proc Natl Acad Sci USA 1989; 86: 5424-5428.
12. Baron Van Evercooren A, Leprince P, Rogister B, et al: Plasminogen activators in developing peripheral nervous system, cellular origin and mitogenic effect. Brain Res 1987; 433: 101-108.
13. Moonen G, Grau Wagemans M P, Selak I, et al. Plasminogen activator is a mitogen for astrocytes in developing cerebellum. Brain Res 1985; 352: 41-48.
14. Rabbani S A, Desjardins J, Bell A W, et al. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem Biophys Res Commun 1990; 173: 1058-1064.
15. Lund L R, Romer J, Ronne E, Ellis V, Blasi F, Danø K. Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells. EMBO J 1991; 10: 3399-3407
16. Nykjaer A, Møller B, Todd R F, et al. Urokinase receptor. An activation antigen in human T lymphocytes. J Immunol 1994; 152: 505-516.
17. Kirchheimer J C, Binder B R. Function of receptor-bound urokinase. Semin Thromb Hemost 1991; 17: 246-250.
18. Mignatti P, Mazzieri R, Rifkin D B. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 1991; 113: 1193-1201.
19. Stoppelli M P, Corti A, Soffientini A, Cassani G, Blasi F, Assoian R K. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 1985; 82: 4939-4943.
20. Lund L R, Ronne E, Roldan A L, et al. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J Biol Chem 1991; 266: 5177-5181.
21. Min H Y, Semnani R, Mizukami I F, Watt K, Todd R F, Liu D Y. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol 1992; 148: 3636-3642.
22. Estreicher A, Muhlhauser J, Carpentier J L, Orci L, Vassalli J D. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 1990; 111: 783-792.
23. Nykjaer A, Petersen C M, Møller B, et al. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J Biol Chem 1992; 267: 14543-14546.
24. Cubellis M V, Wun T C, Blasi F. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBOJ 1990; 9: 1079-1085.
25. Nykjaer A, Conese M, Christensen E I, et al. Recycling of the urokinase receptor upon internalization of the uPA: serpin complexes. EMBOJ 1997; 16: 2610-2620.
26. Pedersen N, Schmitt M, Ronne E, et al. A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer. J Clin Invest 1993; 92: 2160-2167
27. Wilhelm O G, Wilhelm S, Escott G, Brunner G. A cellular GPI-specific phospholipase D regulates the biological function of the urokinase receptor. Fibrinolysis & Proteolysis 1997; 11 (Suppl 3): abstract 128.
28. Wilhelm O G, Wilhelm S, Escott G, et al. GPI-Specific Phospholipase D Releases and Modulates Urokinase Receptor (uPAR, CD 87)-Mediated Functions. 1997; (UnPub)
29. Stephens R W, Hamers MJAG, Nielsen H J, et al. suPAR in the Blood of Healthy Donors and Cancer Patients: Domain Composition and Prognostic Value. 1997; (UnPub)
30. Høyer-Hansen G, Ronne E, Solberg H, et al. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem 1992; 267: 18224-18229.
31. Nykjaer A. Role of Endocytotic Receptors in Modulation of Urokinase Receptor Cell Surface Expression. (UnPub)
32. Behrendt N, Engelholm L, Jensen O N, et al. Identification of a Novel Membrane Protein that Interacts Specifically with the uPAR-Prourokinase Complex. Fibrinolysis & Proteolysis 1997; 11, suppl.3: abstract 34(Abstract)
33. Wei Y, Waltz D A, Rao N, Drummond RJ, Rosenberg S, Chapman H A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994; 269: 32380-32388.
34. Deng G, Curriden S A, Wang S, Rosenberg S, Loskutoff D J. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?. J Cell Biol 1996; 134: 1563-1571.
35. Kanse S M, Kost C, Wilhelm O G, Andreasen P A, Preissner K T. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 1996; 224: 344-353.
36. Waltz D A, Natkin L R, Fujita R M, Wei Y, Chapman H A. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest 1997; 100: 58-67.
37. Stahl A, Mueller B M. Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system. Int J Cancer 1997; 71: 116-122.
38. Preissner K T, May A E, Wohn K D, Germer M, Kanse S M. Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodelling. Thromb Haemost 1997; 78: 88-95.
39. Bohuslav J, Horejsi V, Hansmann C, et al. Urokinase plasminogen activator receptor, beta 2-integrins, and Srckinases within a single receptor complex of human monocytes. J Exp Med 1995; 181: 1381-1390.
40. Sitrin R G, Todd R F, Albrecht E, Gyetko M R. The urokinase receptor (CD87) facilitates GD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 1996; 97: 1942-1951.
41. Godar S, Stockinger H. 1998; (UnPub)
42. Xue W, Kindzelskii A L, Todd R F, Petty H R. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol 1994; 152: 4630-4640.
43. Cao D, Mizukami IF, Garni Wagner B A, et al. Human urokinase-type plasminogen activator primes neutrophils for Superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol 1995; 154: 1817-1829.
44. Kindzelskii A L, Laska Z O, Todd R F, Petty H R. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2′ CD11b/CD18) during neutrophil polarization. J Immunol 1996; 156: 297-309.
45. Kindzelskii A L, Eszes M M, Todd R F, Petty H R. Proximity oscillations of complement type 4 (alpha X beta 2) and urokinase receptors on migrating neutrophils. Biophys J 1997; 73: 1777-1784.
46. Xue W, Mizukami I, Todd R F, Petty H R. Urokinase-type plasminogen activator receptors associate with beta 1 and beta 3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res 1997; 57: 1682-1689.
47. Yebra M, Parry G C N, Stromblad S, et al. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J Biol Chem 1996; 271: 29393-29399.
48. Rothberg K G, Heuser J E, Donzell W C, Ying Y S, Glenney J R, Anderson R G. Caveolin, a protein component of caveolae membrane coats. Cell 1992; 68: 673-682.
49. Sargiacomo M, Sudol M, Tang Z, Lisanti M P. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 1993; 122: 789-807
50. Stahl A, Mueller B M. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 1995; 129: 335-344.
51. Schnitzer J E, McIntosh D P, Dvorak A M, Liu J, Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins [see comments]. Science 1995; 269: 1435-1439.
52. Monier S, Parton R G, Vogel F, Behlke J, Henske A, Kurzchalia T V. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol Biol Cell 1995; 6: 911-927.
53. Ruthner M, Koshelnick Y, Binder B R. Signal transduction and biologic effects induced by crosslinking of receptor-bound urokinase in the human kidney epithelial cell line TCL-598. Fibrinolysis 1996; 10 (Suppl 3): abstract 49.
54. Ehart M, Koshelnick Y, Hufnagl P, Binder B R. Signal Transduction and Biologic Effects induced by Crosslinking of Receptor-Bound Urokinase in the Human Kidney Epithelial Tumor Cell Line TCL-598. 1997; (UnPub).
55. Koshelnick Y, Ehart M, Hufnagl P, Heinrich P C, Binder B R. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem 1997; 272: 28563-28567.
56. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 1996; 15: 1572-1582.
57. Dumler I, Petri T, Schleuning W D. Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett 1993; 322: 37-40.
58. Busso N, Masur S K, Lazega D, Waxman S, Ossowski L. Induction of cell migration by prourokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 1994; 126: 259-270.
59. Blasi F, Fazioli F, Resnati M, Sidenius N, Rabbani S A, Degryse B. The urokinase-sensitive region of the urokinase receptor is responsible for its potent chemotactic activity. Fibrinolysis & Proteolysis 1997; 11 (Suppl 3): abstract 33.
60. Fazioli F, Resnati M, Sidenius N, Riittinen L, Blasi F. Structural and functional specifity of the domain of the human urokinase receptor in cell migration. Fibrinolysis 1996; 10 (suppl 3): abstract 50.
61. Ruthner M, Binder B R. Signal transduction via the urokinase receptor is dependent on both ligand binding and clustering of the receptor in human tumour cell lines. Fibrinolysis 1994; 8 (Suppl 1): abstract 271.
62. Schleuning W D, Konakova M, Hucho F. Cytokine-Like Activities of DFP-Inactivated uPA. Fibrinolysis & Proteolysis 1997; 11 (suppl 3): abstract 32.
63. Stefanova I, Horejsi V, Ansotegui I J, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 1991; 254: 1016-1019.
64. Stefanova I, Corcoran M L, Horak E M, Wahl L M, Bolen J B, Horak I D. Lipopolysaccharide induces activation of CD 14-associated protein tyrosine kinase p53/5611yn. J Biol Chem 1993; 268: 20725-20728.
65. Yebra M, Mueller BM. uPA/uPAR Stimulates Tumor Cell Migration by Enhancing Integrin-Mediated Signal Transduction. Fibrinolysis & Proteolysis 1997; 11 (Suppl 3): abstract 31.
66. Dumler I, Weis A, Mayboroda O A, et al. The jak/stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 1998; 273: 315-321.
67. Dear A E, Medcalf R L: Urokinase mediated induction of an Interferon (IFN) responsive gene promoter may utilise IFN alpha-stimulated gene response elements (ISRE). Fibrinolysis & Proteolysis 1997; 11 (Suppl 3): abstract 19.
68. Dumler I, Petri T, Schleuning W D. Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells. FEBS Lett 1994; 343: 103-106.
69. Rabbani S A, Gladu J, Mazar A P, Henkin J, Goltzman D. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase. J Cell Physiol 1997; 172: 137-145.
70. Del Rosso M, Anichini E, Pedersen N, et al. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun 1993; 190: 347-352.
71. Anichini E, Fibbi G, Pucci M, Caldini R, Chevanne M, Del Rosso M. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Exp Cell Res 1994; 213: 438-448.
72. Anichini E, Zamperini A, Chevanne M, et al. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters. Biochemistry 1997; 36: 3076-3083.
73. Wang N, Planus E, Pouchelet M, Fredberg JJ, Barlovatz Meimon G. Urokinase receptor mediates mechanical force transfer across the cell surface. Am J Physiol 1995; 268: C1062-C1066.
74. Preissner K T, May A M, Kause S M. Protease receptor cross-talk with integrins. 1997; (Unpublished)